Celebrating 25 years Est 1999-2024
*Across 3 years $2276.64 only $796.82
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 ...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...
Micrus Endovascular Corporation (NASDAQ: MEND) announced today that its stockholders approved a proposal to adopt the merger...
Standard & Poor's Announces Change to U.S. Index PR Newswire NEW YORK, Sept. 14 NEW YORK, Sept. 14 /PRNewswire/ -- Monolithic Power Systems, Inc...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K ...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
SCHEDULE 13G Amendment No. 4 MICRUS ENDOVASCULAR CORP Common Stock Cusip #59518V102 Cusip #59518V102 Item 1: Reporting Person - FMR LLC Item 4:...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.